期刊文献+

stat-3与survivin在乳腺癌的表达及其意义 被引量:1

Expression of stat-3 and survivin in breast carcinoma and its significance
暂未订购
导出
摘要 目的:通过检测信号转导与激活因子3(stat-3)与生存素(survivin)在乳腺癌组织中的表达,探讨它们在乳腺癌发生及发展中的意义。方法:应用免疫组织化学法,检测51例乳腺癌和25例癌旁乳腺组织中stat-3和survivin表达。结果:stat-3在乳腺癌中的表达阳性率高于癌旁乳腺组织(P<0.001);stat-3表达在淋巴结转移组中高于无淋巴结转移组(P<0.05)。stat-3表达与患者年龄、肿瘤大小、组织学分级、临床分期、雌孕激素受体和c-erbB-2均无明显关系(P>0.05)。survivin在乳腺癌中的表达高于癌旁乳腺组织(P<0.001);survivin表达与患者年龄、肿瘤大小、组织学分级、临床分期、淋巴结转移、雌孕激素受体和c-erbB-2均无明显关系(P>0.05)。survivin表达阳性者35例中stat-3表达阳性34例,两者表达呈正相关关系(P<0.05)。结论:stat-3、survivin可能相互协同通过抑制细胞凋亡,在乳腺癌发生、发展中起重要作用。 Objective :To investigate the significance of the expression of stat-3 and survivin in the genesis and development of breast carcinoma. Methods: Immunohistochemistry S-P was utilized to measure the expression of stat-3 and survivin protein in 51 breast carcinoma tissues and 25 adjacent noncarcerous tissues. Results:The expression of stat-3 protein was higher in breast carcinoma tissues than that in the adjacent noncarcerous tissues (P 〈 0. 001 ) ;the expression of stat-3 protein was higher in the positive lymph node group than in the negative lymph node group (P 〈 0.05 ). It was not related to the patients' age, size of tumor, pathological grades, clinical stages, ER, PR or cerbB-2 ( P 〉 0.05 ). The expression of survivin protein was higer in breast carcinoma tissues than in the adjacent noncarcerous tissues, and the difference was significant (P 〈 0. 001 ). The expression of survivin protein had no significant coorelation with the patients'age, size of tumor, pathological grades, clinical stages, lymph node metastasis, ER, PR or cerbB-2 ( P 〉 0. 05 ). Of the 35 cases with positive survivin protein expression, positive stat-3 protein was detected in 34 of them. The expression of survivin and stat- 3 had positive correlation in breast carcinoma ( P 〈 0. 05 ). Conclusions: stat-3 and survivin may play an important role in the carcinogensis and progression of breast carcinoma by inhibiting apoptosis.
出处 《蚌埠医学院学报》 CAS 2009年第7期584-587,共4页 Journal of Bengbu Medical College
关键词 乳腺肿瘤 免疫组织化学 细胞凋亡 激活因子3 生存素 breast neoplasms immunohistochemistry apoptosis stat-3 survivin
  • 相关文献

参考文献2

二级参考文献7

  • 1Yu H, Jove R. The Stats of cancer-new molecular targets come of age[J]. Nat Rev Cancer, 2004,4 (2) :97-105.
  • 2Kirkeby S, Thomsen C E. Quantifitive immunohistochemistry of fluorescence labeled probes using lowcost software[J]. J Immunol Methods, 2005,301 ( 1 -2):102-113.
  • 3Levy D E, Lee C K. What does STAT3 do[J]? J Clin Invest,2002,109(9) :1143-1148.
  • 4Grandis J R, Drenning S D, Zeng Q, et al . Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo [J]. Proc Natl Acad Sci USA,2000,97(8) :4227-4232.
  • 5Wang S, Evers B M. Caco-2 cell differentiation is associated with a decrease in Stat protein levels and binding[J]. J Gastroentest Surg, 1999,3(2) : 200- 207.
  • 6梁斌,王杉,祝学光,于永祥,马向涛,崔志荣.转录信号传导子和激活子3在人胃癌组织中的表达及意义[J].中华实验外科杂志,2001,18(4):313-314. 被引量:30
  • 7马向涛,王杉,杜如昱,叶颖江,梁斌,王仲照,崔志荣.癌基因Stat3与结直肠癌临床病理特征的关系[J].中华普通外科杂志,2002,17(7):401-403. 被引量:9

共引文献25

同被引文献13

  • 1毛杰,海健,舒衡平,唐利立,申正堂,邬玉辉,欧慧英.乳腺癌组织中survivin,p53蛋白的表达与预后的关系[J].中国普通外科杂志,2005,14(4):265-268. 被引量:25
  • 2陈刚,周福祥,高霞,夏东.Survivin在乳腺癌中的表达及其与Caspase-3、PCNA表达的关系[J].实用肿瘤学杂志,2005,19(5):340-343. 被引量:5
  • 3Polyak K, Kato JK, Solom on MJ, et al. p27 Kip 1, a cyclin-Cdk inhibing links transforming growth faetorbeta and contact inhibing to cell cycle arrest[ J]. Genes Dev, 1994,8 ( 1 ) :9-22.
  • 4Bear HD, Aaderson S, Brown A, et al. The effect on tumor re- sponse of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from Nation- al Surgical Adjuvant Breast and Bowel Project Procotol B-27 [ J]. J Clin Oncol, 2003,21 (22) :4165.
  • 5Barnes A, Pinder SE, Bell JA, et al. Expression of p27Kipl in breast cancer and its prognostic significance [ J ]. Pathology, 2003, 201 ( 3 ) :451-459.
  • 6Porter PL, Barlow WE, Yeh IT, et al. p27Kipl and cyclin E ex- pression and breast cancer survival after treatment with adjuvantchemotherapy[ J ]. Natl Cancer Inst, 2006,98 (23) : 1723-1731.
  • 7Deveraux QL, Reed JC. IAP family protein-suppressiors of apoptosis [J]. Genes Dev, 1999,13(3) :239-252.
  • 8Youssef NS, Hewedi IH, Abd Raboh NM, et al. Immunohistochem- ical expression of surviving in breast carcinoma: relationship with clinicopathological parameters, proliferation and molecular classifiea- tion[J]. J Egypt Natl Cane Inst, 2008,20(4) :348-357.
  • 9Dogu GG, Ozkan M, Ozturk F, et al. Triple-negtive breast cancer inmmunohistochemieal correlation with basaloid markers and prog- nostic value of survivin [ J]. Med Oncol, 2010,27 (1) :34-39.
  • 10Nam S, Buettner R, Turkson J, et al. Indinubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells[ J]. Proc Natl Acad Sci, 2005,102 (17) :5998-6003.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部